VRTX Award Disclosure
Ambrose Kristen · SEC Form 4 · Filed Sep 1, 2026
Award
Calculated transaction value
$0
Ambrose Kristen SVP & Chief Accounting Officer
VRTX
Transaction date
Aug 28, 2026
Public filing date
Sep 1, 2026
Filing lag
Filed 4 days later
VRTX daily price context
Close on/before transaction
$541.69
Aug 28, 2026
Close before public filing
$544.52
Aug 31, 2026
Return since public filing
-5.51%
Through Sep 11, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 5,000 shares @ $0
- SEC ownership
- Direct
- Transaction code
- A
- Form
- 4
- Filing identifier
- 0000875320-26-000267
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$0
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Vertex Pharmaceuticals Inc / Ma VRTX Current | Award | Aug 28, 2026 | $0 |